Annual CAPEX
$40.80 M
-$11.47 M-21.94%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual capital expenditures is $40.80 million, with the most recent change of -$11.47 million (-21.94%) on December 31, 2023.
- During the last 3 years, DNA annual CAPEX has fallen by -$17.02 million (-29.44%).
- DNA annual CAPEX is now -29.44% below its all-time high of $57.82 million, reached on December 31, 2020.
Performance
DNA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$15.09 M
-$11.94 M-44.18%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly capital expenditures is $15.09 million, with the most recent change of -$11.94 million (-44.18%) on September 30, 2024.
- Over the past year, DNA quarterly CAPEX has increased by +$11.64 million (+337.87%).
- DNA quarterly CAPEX is now -44.18% below its all-time high of $27.03 million, reached on June 30, 2024.
Performance
DNA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$52.28 M
+$10.71 M+25.76%
September 30, 2024
Summary
- As of February 8, 2025, DNA TTM capital expenditures is $52.28 million, with the most recent change of +$10.71 million (+25.76%) on September 30, 2024.
- Over the past year, DNA TTM CAPEX has increased by +$11.48 million (+28.13%).
- DNA TTM CAPEX is now -27.49% below its all-time high of $72.09 million, reached on June 30, 2023.
Performance
DNA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
DNA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.9% | +337.9% | +28.1% |
| 3 y3 years | -29.4% | +337.9% | +28.1% |
| 5 y5 years | +83.6% | - | - |
DNA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.8% | at low | -44.2% | +337.9% | -27.5% | +120.5% |
| 5 y | 5-year | -29.4% | +83.6% | -44.2% | +337.9% | -27.5% | +138.3% |
| alltime | all time | -29.4% | +83.6% | -44.2% | +337.9% | -27.5% | +138.3% |
Ginkgo Bioworks Holdings CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $15.09 M(-44.2%) | $52.28 M(+25.8%) |
| Jun 2024 | - | $27.03 M(+302.9%) | $41.57 M(+48.1%) |
| Mar 2024 | - | $6.71 M(+94.7%) | $28.07 M(-31.2%) |
| Dec 2023 | $40.80 M(-21.9%) | $3.45 M(-21.3%) | $40.80 M(-35.2%) |
| Sep 2023 | - | $4.38 M(-67.6%) | $63.00 M(-12.6%) |
| Jun 2023 | - | $13.53 M(-30.4%) | $72.09 M(+5.8%) |
| Mar 2023 | - | $19.44 M(-24.2%) | $68.13 M(+30.3%) |
| Dec 2022 | $52.27 M | $25.64 M(+90.3%) | $52.27 M(+64.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $13.47 M(+40.7%) | $31.74 M(+33.9%) |
| Jun 2022 | - | $9.57 M(+167.4%) | $23.70 M(-37.9%) |
| Mar 2022 | - | $3.58 M(-30.0%) | $38.17 M(-32.5%) |
| Dec 2021 | $56.52 M(-2.2%) | $5.11 M(-6.0%) | $56.52 M(+9.9%) |
| Sep 2021 | - | $5.44 M(-77.4%) | $51.41 M(+11.8%) |
| Jun 2021 | - | $24.03 M(+9.6%) | $45.97 M(+109.6%) |
| Mar 2021 | - | $21.93 M | $21.93 M |
| Dec 2020 | $57.82 M(+160.2%) | - | - |
| Dec 2019 | $22.22 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual capital expenditures?
- What is the all time high annual CAPEX for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual CAPEX year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly CAPEX year-on-year change?
- What is Ginkgo Bioworks Holdings TTM capital expenditures?
- What is the all time high TTM CAPEX for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM CAPEX year-on-year change?
What is Ginkgo Bioworks Holdings annual capital expenditures?
The current annual CAPEX of DNA is $40.80 M
What is the all time high annual CAPEX for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual capital expenditures is $57.82 M
What is Ginkgo Bioworks Holdings annual CAPEX year-on-year change?
Over the past year, DNA annual capital expenditures has changed by -$11.47 M (-21.94%)
What is Ginkgo Bioworks Holdings quarterly capital expenditures?
The current quarterly CAPEX of DNA is $15.09 M
What is the all time high quarterly CAPEX for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly capital expenditures is $27.03 M
What is Ginkgo Bioworks Holdings quarterly CAPEX year-on-year change?
Over the past year, DNA quarterly capital expenditures has changed by +$11.64 M (+337.87%)
What is Ginkgo Bioworks Holdings TTM capital expenditures?
The current TTM CAPEX of DNA is $52.28 M
What is the all time high TTM CAPEX for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM capital expenditures is $72.09 M
What is Ginkgo Bioworks Holdings TTM CAPEX year-on-year change?
Over the past year, DNA TTM capital expenditures has changed by +$11.48 M (+28.13%)